Correlation Between Viridian Therapeutics and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Mink Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Mink Therapeutics.
Diversification Opportunities for Viridian Therapeutics and Mink Therapeutics
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Viridian and Mink is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Mink Therapeutics
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.68 times more return on investment than Mink Therapeutics. However, Viridian Therapeutics is 1.47 times less risky than Mink Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 2,750 in Viridian Therapeutics on August 23, 2024 and sell it today you would lose (771.00) from holding Viridian Therapeutics or give up 28.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Mink Therapeutics
Performance |
| Timeline |
| Viridian Therapeutics |
| Mink Therapeutics |
Viridian Therapeutics and Mink Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Mink Therapeutics
The main advantage of trading using opposite Viridian Therapeutics and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |